SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-19-001293
Filing Date
2019-03-15
Accepted
2019-03-15 09:09:15
Documents
11
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 20-F a2238084z20-f.htm 20-F 622924
2 EX-4.1 a2238084zex-4_1.htm EX-4.1 1471710
3 EX-12.1 a2238084zex-12_1.htm EX-12.1 6442
4 EX-12.2 a2238084zex-12_2.htm EX-12.2 6430
5 EX-13.1 a2238084zex-13_1.htm EX-13.1 3443
6 EX-13.2 a2238084zex-13_2.htm EX-13.2 3549
7 G486533.JPG g486533.jpg GRAPHIC 89232
8 G625487.JPG g625487.jpg GRAPHIC 5778
9 G286412.JPG g286412.jpg GRAPHIC 5376
10 G89052.JPG g89052.jpg GRAPHIC 6645
11 G122262.JPG g122262.jpg GRAPHIC 3606
  Complete submission text file 0001047469-19-001293.txt   2268599
Mailing Address SMEDELAND 36 2600 GLOSTRUP COPENHAGEN G7 00000
Business Address SMEDELAND 36 2600 GLOSTRUP COPENHAGEN G7 00000 4588773600
Zealand Pharma A/S (Filer) CIK: 0001674988 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-38178 | Film No.: 19683163
SIC: 2834 Pharmaceutical Preparations